ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Correction for McLaughlin et al., Eur Respir J 25 (2) 244-249.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Eur Respir J 2005; 25:942
Copyright ©ERS Journals Ltd 2005

"Survival with first-line bosentan in patients with primary pulmonary hypertension". V. V. McLaughlin, O. Sitbon, D. B. Badesch, R. J. Barst, C. Black, N. Galiè, M. Rainisio, G. Simonneau, and L. J. Rubin. Eur Respir J 2005; 25: 244–249.

Unfortunately, an incorrect sentence from an early draft was inadvertently included in the final version of this manuscript. Thus, the sentence "Of the initial cohort, 78% and 55% of patients were alive and on bosentan monotherapy at 1 and 2 yrs, respectively" (final sentence in the left-hand column of page 246) should be removed in its entirety from the paper.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS